Why the study?
Does pre-existing pulmonary hypertension predict adverse in-hospital and post-discharge outcomes in ACS patients undergoing PCI?
Cohort (n=3,022)
No
Does pre-existing pulmonary hypertension predict adverse in-hospital and post-discharge outcomes in ACS patients undergoing PCI?
Answers are grounded in this paper and cite their sources.
Pre-existing pulmonary hypertension in ACS patients undergoing PCI is associated with an increased risk of hemodynamic and congestion-related complications, including cardiogenic shock and heart failure.
BACKGROUND Pulmonary hypertension (PH) may compromise hemodynamic tolerance during acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI). Current ACS risk tools do not incorporate pulmonary hypertension status and procedure-level outcome data remain limited. OBJECTIVES To determine whether pre-existing PH independently predicts adverse in-hospital and post-discharge outcomes in ACS patients undergoing PCI. METHODS Single-center retrospective cohort study of consecutive PCI procedures for ACS (2012 to 2017) using an institutional PCI Registry. The primary composite outcome included in-hospital death, cardiogenic shock, or significant arrhythmia. Secondary endpoints included AKI, major bleeding, in-hospital HF, and post-discharge events at 30 days, 6 months, and 1 year. Multivariable logistic regression adjusted for sex, hypertension, hyperlipidemia, diabetes, smoking, prior CAD, peripheral artery disease, CKD, prior TIA/stroke, and anemia. RESULTS Among 3022 patients, 158 (5.23%) had PH. PH patients were older (67.0 vs. 64.8 years, p = 0.023) with greater comorbidity burden. After adjustment, PH independently predicted AKI (aOR 1.72; 95% CI 1.01 to 2.93; p = 0.046), cardiogenic shock (aOR 3.32; 95% CI 1.59 to 6.95; p = 0.001), and in-hospital HF (aOR 2.15; 95% CI 1.15 to 4.02; p = 0.017). At 6 months, PH was associated with HF readmission (aOR 2.12; p = 0.024) and stroke (aOR 4.28; p = 0.027). Adjusted mortality, recurrent ACS, and reintervention rates were similar across all time points. CONCLUSIONS Among ACS patients undergoing PCI, PH identifies a high-risk phenotype characterized by congestion-related and hemodynamic complications rather than atherothrombotic recurrence. The temporal risk evolution suggests distinct pathophysiological mechanisms requiring targeted interventions.
No takes yet. Share an insight, caveat, or question.
Awad et al. (2026) conducted a cohort in Acute coronary syndrome (n=3,022). Pre-existing pulmonary hypertension vs. No pulmonary hypertension was evaluated on Composite of in-hospital death, cardiogenic shock, or significant arrhythmia.
Synapse has enriched 10 related papers. Consider them for comparative context: